AI in Clinical Trials Market (By Offering: Software, Services; By Technology: Machine learning, Deep learning, Supervised; By Application: Cardiovascular, Metabolic, Oncology, Infectious diseases; By End-user: Pharma, Biotech, CROs) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: AI in Clinical Trials Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. AI in Clinical Trials Market, by Offering, 2024-2033
8.1.1. Software
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Services
8.1.2.1. Market Revenue and Forecast (2021-2033)
9.1. AI in Clinical Trials Market, by Technology, 2024-2033
9.1.1. Machine learning
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Deep learning
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Supervised
9.1.3.1. Market Revenue and Forecast (2021-2033)
10.1. AI in Clinical Trials Market, by Application, 2024-2033
10.1.1. Cardiovascular
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Metabolic
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Oncology
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Infectious diseases
10.1.4.1. Market Revenue and Forecast (2021-2033)
11.1. AI in Clinical Trials Market, by End-user, 2024-2033
11.1.1. Pharma
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Biotech
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. CROs
11.1.3.1. Market Revenue and Forecast (2021-2033)
12.1. North America
12.1.1. Market Revenue and Forecast, by Offering (2021-2033)
12.1.2. Market Revenue and Forecast, by Technology (2021-2033)
12.1.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.4. Market Revenue and Forecast, by End-user (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Offering (2021-2033)
12.1.5.2. Market Revenue and Forecast, by Technology (2021-2033)
12.1.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.5.4. Market Revenue and Forecast, by End-user (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Offering (2021-2033)
12.1.6.2. Market Revenue and Forecast, by Technology (2021-2033)
12.1.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.6.4. Market Revenue and Forecast, by End-user (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Offering (2021-2033)
12.2.2. Market Revenue and Forecast, by Technology (2021-2033)
12.2.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.4. Market Revenue and Forecast, by End-user (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Offering (2021-2033)
12.2.5.2. Market Revenue and Forecast, by Technology (2021-2033)
12.2.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.5.4. Market Revenue and Forecast, by End-user (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Offering (2021-2033)
12.2.6.2. Market Revenue and Forecast, by Technology (2021-2033)
12.2.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.6.4. Market Revenue and Forecast, by End-user (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Offering (2021-2033)
12.2.7.2. Market Revenue and Forecast, by Technology (2021-2033)
12.2.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.7.4. Market Revenue and Forecast, by End-user (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Offering (2021-2033)
12.2.8.2. Market Revenue and Forecast, by Technology (2021-2033)
12.2.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.8.4. Market Revenue and Forecast, by End-user (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Offering (2021-2033)
12.3.2. Market Revenue and Forecast, by Technology (2021-2033)
12.3.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.4. Market Revenue and Forecast, by End-user (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Offering (2021-2033)
12.3.5.2. Market Revenue and Forecast, by Technology (2021-2033)
12.3.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.5.4. Market Revenue and Forecast, by End-user (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Offering (2021-2033)
12.3.6.2. Market Revenue and Forecast, by Technology (2021-2033)
12.3.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.6.4. Market Revenue and Forecast, by End-user (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Offering (2021-2033)
12.3.7.2. Market Revenue and Forecast, by Technology (2021-2033)
12.3.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.7.4. Market Revenue and Forecast, by End-user (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Offering (2021-2033)
12.3.8.2. Market Revenue and Forecast, by Technology (2021-2033)
12.3.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.8.4. Market Revenue and Forecast, by End-user (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Offering (2021-2033)
12.4.2. Market Revenue and Forecast, by Technology (2021-2033)
12.4.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.4. Market Revenue and Forecast, by End-user (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Offering (2021-2033)
12.4.5.2. Market Revenue and Forecast, by Technology (2021-2033)
12.4.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.5.4. Market Revenue and Forecast, by End-user (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Offering (2021-2033)
12.4.6.2. Market Revenue and Forecast, by Technology (2021-2033)
12.4.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.6.4. Market Revenue and Forecast, by End-user (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Offering (2021-2033)
12.4.7.2. Market Revenue and Forecast, by Technology (2021-2033)
12.4.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.7.4. Market Revenue and Forecast, by End-user (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Offering (2021-2033)
12.4.8.2. Market Revenue and Forecast, by Technology (2021-2033)
12.4.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.8.4. Market Revenue and Forecast, by End-user (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Offering (2021-2033)
12.5.2. Market Revenue and Forecast, by Technology (2021-2033)
12.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.4. Market Revenue and Forecast, by End-user (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Offering (2021-2033)
12.5.5.2. Market Revenue and Forecast, by Technology (2021-2033)
12.5.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.5.4. Market Revenue and Forecast, by End-user (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Offering (2021-2033)
12.5.6.2. Market Revenue and Forecast, by Technology (2021-2033)
12.5.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.6.4. Market Revenue and Forecast, by End-user (2021-2033)
13.1. AiCure
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Antidote Technologies
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Deep 6 AI
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Mendel.ai
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Phesi
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Saama Technologies
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Signant Health
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Trials.ai
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Innoplexus
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. IQVIA
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample